Intriguingly, we discovered that NRN1 was negatively correlated with Aβ42, β-, and γ-secretase activities, suggesting it may be a potential indicator for determining the severity of pathologic alterations in AD (Figures 11C–E). Here, NRN1 is linked to Alzheimer disease.